Navigation Links
Masimo Reports Fourth Quarter and Full Year 2010 Financial Results; Provides 2011 Guidance
Date:2/15/2011

venue, royalty revenue and product revenue, including rainbow revenue, and GAAP earnings per share for the full fiscal year 2011.  These forward-looking statements are based on management's current expectations and beliefs and are subject to uncertainties and factors, all of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to: our dependence on Masimo SET and Masimo rainbow SET products and technologies for substantially all of our revenue; any failure in protecting our intellectual property exposure to competitors' assertions of intellectual property claims; the highly competitive nature of the markets in which we sell our products and technologies; any failure to continue developing innovative products and technologies; the lack of acceptance of any of our current or future products and technologies; obtaining regulatory approval of our current and future products and technologies; the risk that the implementation of our international realignment will not continue to produce anticipated operational and financial benefits, including a continued lower effective tax rate; the loss of our customers; the failure to retain and recruit senior management; product liability claims exposure; a failure to obtain expected returns from the amount of intangible assets we have recorded; the maintenance of our brand; the impact of the decline in the worldwide credit markets on us and our customers; the amount and type of equity awards that we may grant to employees and service providers in the future; and other factors discussed in the "Risk Factors" section of our most recent periodic reports filed with the Securities and Exchange Commission ("SEC"), which you may obtain for free on the SEC's website at www.sec.gov. Although we believe that
'/>"/>
SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Mafraq Hospital Becomes First in United Arab Emirates to Deploy Masimo rainbow SET Pulse CO-Oximetry for State-of-the-Art Noninvasive Patient Monitoring
2. Welch Allyn Establishes Strategic Partnership to Incorporate Masimo rainbow® SET Noninvasive Measurement Capabilities in Next-Generation Patient Monitors
3. New Published Study Finds Noninvasive Masimo PVI Accurately Predicts Fluid Responsiveness in Intensive Care Patients
4. Masimo to Report Fourth Quarter and Full Year 2010 Financial Results After Market Close on February 15, 2011
5. Masimo to Present at 29th Annual J.P. Morgan Healthcare Conference
6. New Clinical Study Presented at the American Association of Respiratory Care Finds Masimo Rainbow Acoustic Monitoring Accurate for Respiration Rate Assessment
7. Masimo to Present at Piper Jaffray 22nd Annual Healthcare Conference
8. Prime Healthcare Converts System-Wide to Masimo rainbow SET Technology
9. BMEYE Receives FDA Clearance to Launch ccNexfin, the First Totally Noninvasive Cardiovascular Monitor With BP, CO, and Masimo Rainbow SET(R) Technology in the United States
10. Masimo to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11. Masimo Reports Third Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... , August 28, 2015 The scientific ... collaboration with one of the leading academics in the field ... world record holder in life extension for model animals - ... biology of aging and age-related diseases, primarily, around the stability ... has just been published as "Stability analysis of a model ...
(Date:8/28/2015)... , Aug. 28, 2015  Perrigo Company plc ... it has completed the acquisition of leading OTC brands ... €200 million. The transaction is a clear demonstration of ... Company,s leading European distribution network spanning 36 countries.  ... C. Papa commented, "We are excited to complete ...
Breaking Medicine Technology:China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) ... company at the Bank of America Merrill Lynch Healthcare conference in ... Las Vegas, NV Presentation date: Tuesday May 10, 2011 ... A live webcast and 30-day archive of this presentation ...
... MELVILLE, N.Y., May 3, 2011 Henry Schein, ... healthcare products and services to office-based practitioners, today reported record ... Net sales for the first quarter of 2011 were ... quarter of 2010.  This consists of 9.9% growth in local ...
Cached Medicine Technology:Henry Schein Reports Record First Quarter Results 2Henry Schein Reports Record First Quarter Results 3Henry Schein Reports Record First Quarter Results 4Henry Schein Reports Record First Quarter Results 5Henry Schein Reports Record First Quarter Results 6Henry Schein Reports Record First Quarter Results 7Henry Schein Reports Record First Quarter Results 8Henry Schein Reports Record First Quarter Results 9
(Date:8/29/2015)... AZ (PRWEB) , ... August 30, 2015 , ... ... David O’Shea to serve as the college’s Vice President of Strategic Initiatives and Information ... is eager to help the college expand its reach and impact through innovative technologies ...
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik , ... standard shipping costs. , “Before, a threshold of $49.00 was required to qualify for ... items qualify for free standard shipping for customers regardless of the item’s selling price.” ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring strain ... stretching, soft tissue manipulation. Platelet rich plasma injections also have mixed results. ... improve treatment outcomes. This localized treatment seems to address the symptoms and ...
(Date:8/28/2015)... Sierra Madre, CA (PRWEB) , ... August 28, ... ... alternative solutions to wound center management, Decatur County Memorial Hospital recently transitioned management ... model of Wound Center Management for their outpatient wound center. , ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 2Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 3Health News:Decatur County Memorial Hospital Transitions Wound Center Management To Wound Care Advantage and the Luvo Operating System 4
... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), a ... products, today,announced that it has entered into definitive ... of 8,750,000 shares of,its common stock at $2.40 ... purchase 3,500,000 shares of common stock at an,exercise ...
... Respectively, Over Prior Year ... Period-, EXTON, Pa., ... for its second quarter and six,months of fiscal year 2008., Second Quarter ... income, increased 14% to $19.6 million in the Company,s second,fiscal quarter ended December ...
... Matthew L. Myers ... Tobacco-Free Kids, WASHINGTON, Jan. 24 The following statement,was ... A new global survey released by the U.S. Centers ... use, and even higher,rates of exposure to secondhand smoke, among ...
... 24 Karen Ignagni, President,and CEO of ... statement on,the Institute of Medicine,s (IOM) recommendation ... the effectiveness of healthcare products and,services:, ... deserve to know not only what medical ...
... day low price philosophy helps customers save more ... compared to prescription retail price, BENTONVILLE, Ark., ... recent prescription to over-the-counter (OTC) approved,drug, Zyrtec(R) (cetirizine ... Wal-Mart will offer eight different OTC Zyrtec products, ...
... Department of,Health and Human Services (HHS) Secretary ... standards developed by the Healthcare Information,Technology Standards ... advanced three,of its "Interoperability Specifications" to help ... a Nationwide Health Information Network in,the United ...
Cached Medicine News:Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 2Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 3Health News:MiddleBrook Pharmaceuticals to Raise $21 Million Through Private Placement of Common Equity 4Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 2Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 3Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 4Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 5Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 6Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 7Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 8Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 9Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 10Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 11Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 12Health News:Kensey Nash Reports Second Quarter EPS of $0.21 and Revenue of $19.6 Million 13Health News:New CDC Global Survey Finds Tobacco Taking Massive Toll on World's Children 2Health News:New CDC Global Survey Finds Tobacco Taking Massive Toll on World's Children 3Health News:Wal-Mart Becomes One of the First to Offer Over-the-Counter Zyrtec 2Health News:Wal-Mart Becomes One of the First to Offer Over-the-Counter Zyrtec 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 2Health News:HHS Secretary Recognizes Products of HITSP Standards Work 3Health News:HHS Secretary Recognizes Products of HITSP Standards Work 4
Colloidal Gold Conjugated, Protein A - 12 OD...
Colloidal Gold Conjugated, Protein G - 12 OD...
Colloidal Gold Sol, 40 nm - 12 - 15, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Colloidal Gold Sol, 20 nm - 12 - 15 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: